Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -437 | -175 | -944 | -635 | -455 |
| Depreciation Amortization | 4 | 2 | 7 | 6 | 4 |
| Accounts receivable | -7 | 0 | 10 | 12 | 11 |
| Other Working Capital | 135 | 71 | 391 | 198 | 118 |
| Other Operating Activity | 123 | 59 | 317 | 226 | 165 |
| Operating Cash Flow | $-182 | $-43 | $-220 | $-194 | $-157 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | N/A | N/A | N/A |
| Investing Cash Flow | $-1 | $-1 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 158 | 45 | 70 | 43 | 6 |
| Debt Issued | N/A | N/A | 148 | 149 | 148 |
| Common Stock Issued | 77 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -53 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $183 | $45 | $218 | $191 | $155 |
| Exchange Rate Effect | -1 | 0 | -1 | 0 | 0 |
| Beginning Cash Position | 1 | 1 | 4 | 4 | 4 |
| End Cash Position | 0 | 2 | 1 | 1 | 2 |
| Net Cash Flow | $-1 | $1 | $-3 | $-3 | $-2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -182 | -43 | -220 | -194 | -157 |
| Capital Expenditure | -1 | -1 | N/A | N/A | N/A |
| Free Cash Flow | -183 | -44 | -220 | -194 | -157 |